GoHealth Q1 2024 Adj EPS $(0.85) Beats $(0.95) Estimate, Sales $185.600M Beat $180.154M Estimate
GoHealth Q1 2024 Adj EPS $(0.85) Beats $(0.95) Estimate, Sales $185.600M Beat $180.154M Estimate
GoHealth 2024 年第一季度經調整後每股收益（0.85 美元）超過預期（0.95 美元），銷售額1.856億美元，超過預期 1.80154億美元
GoHealth (NASDAQ:GOCO) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(0.95) by 10.53 percent. The company reported quarterly sales of $185.600 million which beat the analyst consensus estimate of $180.154 million by 3.02 percent. This is a 1.33 percent increase over sales of $183.158 million the same period last year.
GoHealth（納斯達克股票代碼：GOCO）公佈的季度虧損爲每股0.85美元，比分析師普遍預期的0.95美元（0.95美元）高出10.53％。該公司公佈的季度銷售額爲1.856億美元，比分析師普遍預期的1.80154億美元高出3.02％。這比去年同期的1.83158億美元的銷售額增長了1.33％。